Phase i Study of the investigational nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with advanced solid tumors

John Sarantopoulos*, Geoffrey I. Shapiro, Roger B. Cohen, Jeffrey W. Clark, John S. Kauh, Glen J. Weiss, James M. Cleary, Devalingam Mahalingam, Michael D. Pickard, Héléne M. Faessel, Allison J. Berger, Kristine Burke, George Mulligan, Bruce J. Dezube, R. Donald Harvey

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Fingerprint Dive into the research topics of 'Phase i Study of the investigational nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences